comparemela.com
Home
Live Updates
Advisory - Health Canada safety review finds link between th
Advisory - Health Canada safety review finds link between th
Advisory - Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer
/CNW/ - Summary Product: Xeljanz and Xeljanz XR (tofacitinib), a prescription drug used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative...
Related Keywords
Canada ,
Ottawa ,
Ontario ,
Canadians ,
Canadian ,
,
Pfizer ,
Health Canada Web ,
Health Canada ,
Safety Review ,
Adverse Reaction Reporting ,
Health Care Amp Hospitals ,
Canadian Federal Government ,
Public Safety ,